<SEC-DOCUMENT>0001144204-16-090941-index.html : 20160329 <SEC-HEADER>0001144204-16-090941.hdr.sgml : 20160329 <ACCEPTANCE-DATETIME>20160329162259 ACCESSION NUMBER: 0001144204-16-090941 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20160323 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20160329 DATE AS OF CHANGE: 20160329 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NAVIDEA BIOPHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000810509 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 311080091 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35076 FILM NUMBER: 161535637 BUSINESS ADDRESS: STREET 1: 5600 BLAZER PARKWAY STREET 2: SUITE 200 CITY: DUBLIN STATE: OH ZIP: 43017 BUSINESS PHONE: 6147937500 MAIL ADDRESS: STREET 1: 5600 BLAZER PARKWAY STREET 2: SUITE 200 CITY: DUBLIN STATE: OH ZIP: 43017 FORMER COMPANY: FORMER CONFORMED NAME: NEOPROBE CORP DATE OF NAME CHANGE: 19940714 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>v435580_8k.htm <DESCRIPTION>8-K <TEXT> Document 1 - file: v435580_8k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.2 <SEQUENCE>2 <FILENAME>v435580_ex10-2.htm <DESCRIPTION>EXHIBIT 10.2 <TEXT> Document 2 - file: v435580_ex10-2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.3 <SEQUENCE>3 <FILENAME>v435580_ex10-3.htm <DESCRIPTION>EXHIBIT 10.3 <TEXT> Document 3 - file: v435580_ex10-3.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>4 <FILENAME>v435580_ex99-1.htm <DESCRIPTION>EXHIBIT 99.1 <TEXT> Document 4 - file: v435580_ex99-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>image_002.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: image_002.jpg
</DOCUMENT> </SEC-DOCUMENT>